MedTrace Logo

Escitalopram Combination Comparison Study for Adult Patients With Major Depressive Disorder

NCT00239954 · Status: UNKNOWN · Phase: PHASE3 · Type: INTERVENTIONAL

Last updated 2012-05-09

No results posted yet for this study

Summary

The purpose of this study is to evaluate the effectiveness, safety and tolerability of an escitalopram combination treatment compared to single treatments, and to placebo in patients with major depressive disorder.

Conditions

Interventions

DRUG

Escitalopram

Sponsors & Collaborators

  • Pharmacology Research Institute

    lead OTHER

Principal Investigators

  • Jon F. Heiser, MD · Pharmacology Research Institute

  • Nader Oskooilar, MD · Pharmacology Research Institute

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2005-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00239954 on ClinicalTrials.gov